MC1R and melanoma: Thus, for individuals with phenotypes associated with lower to average melanoma risk, MC1R genetic testing can reveal information about melanoma risk not otherwise deduced from clinical observation alone, has the potential to unmask at-risk subgroups in this population who may be unaware of the constitutional risk imparted by their genetic inheritance, and can impact overall melanoma rates [13].